The AISN coordinator, Radboud University, located in Nijmegen, the Netherlands, was established in 1923; it has profiled itself as one of the top-notch educational institutions in Western Europe. Radboud is known for its strong research output. Radboud leads work packages on clinical and acceptance validation as well as the project management, dissemination and stakeholder management.
Saddle Point develops advanced statistical and mathematical techniques, modelling approaches and effective software tools to analyse complex epidemiological and medical trial data. They confront dimension mismatch, latent heterogeneity in disease or host, informative censoring, and confounding factors. Saddle Point leads the AISN platform components work package about AI technology and interfaces
Eodyne has a track record of delivering science-based neurorehabilitation solutions to the market. Eodyne focuses on developing digital health technology and interactive systems to optimize hospital resources and improve user experience and patient outcomes.
EODYNE leads the AISN platform technical integration and clinical trial deployment work package.
EBRAINS is a new digital research infrastructure (RI), created by the EU-funded Human Brain Project (HBP), to foster brain-related research and to help translate the latest scientific discoveries into innovation in medicine and industry, for the benefit of patients and society. EBRAINS leads the developments related to end-to-end workflows from data collection to final output, FAIR Data management and processing, and new branches of the EBRAINS Knowledge Graph for incorporating all specificities of the project.
As a global leader in healthcare technology and with more that 95k employees, our therapies and solutions span the treatment of more than 70 conditions in the human body.
Medtronic leads the innovation management, business, exploitation and sustainability work package.
Parc Sanitari Sant Joan de Déu (PSSJD) is a private non-profit institution and a reference center in integrative and continuous healthcare. In particular, the Neurorehabilitation department headed by Dr. Raffaele Fiorillo is a team focused on innovation and improvement.
The HAVAE team – UR20217 brings together teacher-researchers from various specialities: Sciences and Techniques of Physical and Sports Activities, Physical Medicine and Rehabilitation. The involved laboratory relies on the conceptual model of the ICF (International Classification of Functioning and Disability) through two operational objectives: - Identify determinants of mobility in real-life situations and - Facilitate mobility across real-life situations: home intervention studies
CHARITE (PI Petra Ritter) is experienced leader of large-scale consortia that develop infrastructure for sensitive human digital twin technologies (EOSC project Virtual Brain Cloud, eBRAIN-Health, TEF-Health). PI Ritter is co-lead of The Virtual Brain simulation platform. CHARITE is the leading EBRAINS Service for Sensitive Data: the Health Data Cloud.
The CHU of Limoges has three public service missions: care, teaching, research and innovation. Our staff work in 5 hospitals and a Biology and Health Research Center. Our Inserm-labeled teams and the various and numerous projects recognised at the national and European levels illustrate the will of our University Hospital to develop its research activities.
The Neurorehabilitation unit at the University Hospital Bern offers inpatient and outpatient care for patients with acquired brain injuries in an academic setting. Besides interdisciplinary clinical excellence, we offer expertise in the development of new therapies for rehabilitation based on a multimodal understanding of neural plasticity.
The University of Oxford is a prestigious, globally-renowned academic institution based in Oxford, known for its research excellence and diverse intellectual community. It leads the focus within AISN on the ethical, legal and social aspects of integrating AI in healthcare, focusing on patient values and the doctor-patient relationship, and addressing challenges like consent models, the moral status of brain simulations, data ownership, and bias in AI training. The University of Oxford leads the ELSA (Ethical, Legal and Social Aspects research) work package.